ProPhase Labs, Inc. (OTCPK: PRPH)
Health Care · Pharmaceuticals · US
$0.01
-43.04% today · -99.8% 1Y
ProPhase Labs, Inc. (OTCPK: PRPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $163.08K and employs 19 people.
Over the last twelve months the share price has lost 99.8%, trading between 0.01 and 5.62.
Tweenvest scores ProPhase Labs, Inc. across four factors: quality 28/100, value 58/100, growth 0/100. Its strongest factor is value.
PRPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $163.08K
- Revenue (TTM)
- $3.85M
- P/E
- —
- EPS
- -1.71
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- $5.62
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 18.12M
- Employees
- 19
- Next earnings
- —
About ProPhase Labs, Inc.
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
- ISIN
- US74345W2070
- Founded
- 1989
- Listed since
- Apr 4, 1994
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cresanto Global LimitedBSE: 531207 | $239.54K | Rs— | — |
| Ampio Pharmaceuticals, Inc.OTCPK: AMPE | $207.88K | $— | — |
| China SXT Pharmaceuticals, Inc.NasdaqCM: SXTC | $196.50K | $0.09 | -36.99% |
| GNCC Capital, Inc.OTCPK: GNCP | $174.15K | $0.00 | -99.00% |
| NanoSphere Health Sciences Inc.CNSX: NSHS.X | $144.31K | CA$0.02 | — |
| Resonate Blends, Inc.OTCPK: KOAN | $143.15K | $0.00 | -25.00% |
| Petros Pharmaceuticals, Inc.OTCPK: PTPI | $141.95K | $0.00 | +1.52% |
| Allstar Health Brands, Inc.OTCPK: ALST | $140.05K | $0.00 | -11.11% |
Figures last refreshed Oct 11, 2026.